JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6226
iShares iBonds Dec 2026 Term Treasury ETF
IBTG
$1.97B
| $6.34K | ﹤0.01% |
+277
| New | +$6.33K |
2024 Q4
0 quarters
|
|
6227
First Trust Alerian US NextGen Infrastructure ETF
RBLD
$41.6M
| $6.32K | ﹤0.01% |
+95
| New | +$6.57K |
2024 Q4
0 quarters
|
|
6228
Global X Social Media ETF
SOCL
$89M
| $6.3K | ﹤0.01% |
149
-2,620
| -95% | -$113K |
2023 Q4
4 quarters
|
|
6229
Gran Tierra Energy
GTE
$354M
| $6.3K | ﹤0.01% |
871
+435
| +100% | +$2.83K |
2017 Q2
30 quarters
|
|
6230
Outset Medical
OM
$70.5M
| $6.29K | ﹤0.01% |
377
-683
| -64% | -$8.52K |
2020 Q3
17 quarters
|
|
6231
CALL
Hormel Foods
HRL
$11B
| $6.27K | ﹤0.01% |
200
| – | – |
2024 Q2
2 quarters
|
|
|
6232
PUT
Hormel Foods
HRL
$11B
| $6.27K | ﹤0.01% |
200
| – | – |
2024 Q2
2 quarters
|
|
6233
Northern Trust STOXX Global Broad Infrastructure ETF
NFRA
$2.95B
| $6.23K | ﹤0.01% |
114
| – | – |
2021 Q1
15 quarters
|
|
6234
Immunic
IMUX
$118M
| $6.22K | ﹤0.01% |
622
+581
| +1,417% | +$7.32K |
2020 Q2
18 quarters
|
|
|
FFA
6235
First Trust Enhanced Equity Income Fund
FFA
$444M
| $6.21K | ﹤0.01% |
300
| – | – |
2023 Q2
6 quarters
|
|
6236
Inspire 100 ETF
BIBL
$494M
| $6.19K | ﹤0.01% |
+159
| New | +$6.48K |
2024 Q4
0 quarters
|
|
|
AFEM
6237
First Trust Exchange-Traded Fund III First Trust Active Factor Emerging Markets ETF
AFEM
$83M
| $6.16K | ﹤0.01% |
97
| – | – |
2023 Q1
7 quarters
|
|
6238
Northern Trust Global Quality Real Estate ETF
GQRE
$433M
| $6.15K | ﹤0.01% |
108
+42
| +64% | +$2.54K |
2023 Q1
7 quarters
|
|
6239
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$3.42B
| $6.08K | ﹤0.01% |
307
-2,368
| -89% | -$47.7K |
2024 Q2
2 quarters
|
|
|
GBAB
6240
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust
GBAB
$345M
| $6.08K | ﹤0.01% |
+400
| New | +$6.45K |
2024 Q4
0 quarters
|
|
6241
Aptus Defined Risk ETF
DRSK
$1.43B
| $6.06K | ﹤0.01% |
+221
| New | +$6.19K |
2024 Q4
0 quarters
|
|
6242
Korea Electric Power
KEP
$14.1B
| $6.03K | ﹤0.01% |
877
-295
| -25% | -$2.31K |
2015 Q4
36 quarters
|
|
6243
Banco de Chile
BCH
$19.7B
| $5.96K | ﹤0.01% |
263
+67
| +34% | +$1.58K |
2021 Q3
13 quarters
|
|
6244
Invesco Advantage Municipal Income Trust II
VKI
$332M
| $5.85K | ﹤0.01% |
669
| – | – |
2023 Q4
4 quarters
|
|
6245
FT Vest US Equity Deep Buffer ETF January
DJAN
$482M
| $5.75K | ﹤0.01% |
147
-19,660
| -99% | -$760K |
2023 Q3
5 quarters
|
|
|
CHW
6246
Calamos Global Dynamic Income Fund
CHW
$510M
| $5.71K | ﹤0.01% |
846
| – | – |
2022 Q3
9 quarters
|
|
6247
Tonix Pharmaceuticals
TNXP
$158M
| $5.7K | ﹤0.01% |
+173
| New | +$3.6K |
2024 Q1
3 quarters
|
|
6248
CALL
Lattice Semiconductor
LSCC
$18.3B
| $5.67K | ﹤0.01% |
100
| – | – |
2024 Q1
3 quarters
|
|
6249
Icahn Enterprises
IEP
$4.81B
| $5.63K | ﹤0.01% |
650
| – | – |
2015 Q1
39 quarters
|
|
|
RBOT.WS
6250
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
| – | – |
0
| – | – |
2024 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.